Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells

ABSTRACT: Several viruses can infect the mammalian nervous system and induce neurological dysfunction. Adoptive immunotherapy (AI) is an approach that involves administration of antiviral T cells and has shown promise in clinical studies for the treatment of peripheral virus infections in humans such as cytomegalovirus, Epstein-Barr virus, and adenovirus, among others. Clearance of neurotropic infections, on the other hand, is particularly challenging because the central nervous system (CNS) is relatively intolerant of immunopathological reactions. Therefore, it is essential to develop and mechanistically understand therapies that noncytopathically eradicate pathogens from the CNS. Here, we used mice persistently infected from birth with lymphocytic choriomeningitis virus (LCMV) to demonstrate that

ORGANISM(S): Mus musculus

SUBMITTER: Kory Johnson 

PROVIDER: E-GEOD-66421 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress